Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective

Authors
Murdoch, DR Reller, LB
Citation
Dr. Murdoch et Lb. Reller, Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective, ANTIM AG CH, 45(12), 2001, pp. 3623-3624
Citations number
11
Categorie Soggetti
Microbiology
Journal title
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
ISSN journal
00664804 → ACNP
Volume
45
Issue
12
Year of publication
2001
Pages
3623 - 3624
Database
ISI
SICI code
0066-4804(200112)45:12<3623:ASOGBS>2.0.ZU;2-R
Abstract
Antimicrobial susceptibility testing of 192 group B streptococcal isolates from patients with invasive disease demonstrated that 31 (16%) were resista nt to erythromycin and 17 (9%) were resistant to clindamycin. One isolate d emonstrated high-level resistance to streptomycin, but none was highly resi stant to gentamicin. Erythromycin and clindamycin are no longer reliable em pirical alternatives to penicillin for the treatment and prevention of grou p B streptococcal infections.